Johnson & Johnson (JNJ) Shares Sold by State Board of Administration of Florida Retirement System

State Board of Administration of Florida Retirement System lowered its holdings in Johnson & Johnson (NYSE:JNJ) by 0.4% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 3,913,535 shares of the company’s stock after selling 17,240 shares during the period. Johnson & Johnson makes up 1.4% of State Board of Administration of Florida Retirement System’s holdings, making the stock its 5th biggest holding. State Board of Administration of Florida Retirement System owned approximately 0.15% of Johnson & Johnson worth $508,799,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Landmark Financial Advisors LLC grew its holdings in Johnson & Johnson by 0.4% during the 2nd quarter. Landmark Financial Advisors LLC now owns 1,962 shares of the company’s stock worth $259,000 after acquiring an additional 7 shares in the last quarter. Paradigm Financial Advisors LLC grew its holdings in Johnson & Johnson by 0.3% during the 2nd quarter. Paradigm Financial Advisors LLC now owns 2,649 shares of the company’s stock worth $350,000 after acquiring an additional 9 shares in the last quarter. Premier Asset Management LLC grew its holdings in Johnson & Johnson by 0.4% during the 2nd quarter. Premier Asset Management LLC now owns 2,749 shares of the company’s stock worth $363,000 after acquiring an additional 12 shares in the last quarter. Lbmc Investment Advisors LLC grew its holdings in Johnson & Johnson by 0.4% during the 2nd quarter. Lbmc Investment Advisors LLC now owns 3,718 shares of the company’s stock worth $492,000 after acquiring an additional 14 shares in the last quarter. Finally, Halbert Hargrove Russell LLC grew its holdings in Johnson & Johnson by 0.4% during the 2nd quarter. Halbert Hargrove Russell LLC now owns 3,523 shares of the company’s stock worth $466,000 after acquiring an additional 15 shares in the last quarter. Hedge funds and other institutional investors own 65.53% of the company’s stock.

Several research firms have commented on JNJ. Vetr upgraded shares of Johnson & Johnson from a “hold” rating to a “buy” rating and set a $150.89 price target for the company in a report on Thursday, January 11th. Citigroup upped their target price on shares of Johnson & Johnson from $140.00 to $149.00 and gave the company a “buy” rating in a report on Monday, October 23rd. Stifel Nicolaus upped their target price on shares of Johnson & Johnson from $140.00 to $142.00 and gave the company a “hold” rating in a report on Wednesday, October 18th. Argus upped their target price on shares of Johnson & Johnson from $145.00 to $165.00 and gave the company a “positive” rating in a report on Wednesday, October 18th. Finally, BMO Capital Markets upped their target price on shares of Johnson & Johnson to $161.00 and gave the company an “outperform” rating in a report on Tuesday, December 12th. Four equities research analysts have rated the stock with a sell rating, eight have issued a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $146.16.

Johnson & Johnson (NYSE:JNJ) traded down $0.29 during mid-day trading on Wednesday, reaching $129.67. 6,259,364 shares of the company traded hands, compared to its average volume of 9,410,000. Johnson & Johnson has a 1 year low of $115.32 and a 1 year high of $148.32. The stock has a market cap of $348,360.00, a P/E ratio of 332.49, a price-to-earnings-growth ratio of 2.34 and a beta of 0.74. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.02 and a current ratio of 1.32.

Johnson & Johnson (NYSE:JNJ) last released its quarterly earnings results on Tuesday, January 23rd. The company reported $1.74 EPS for the quarter, beating the consensus estimate of $1.72 by $0.02. Johnson & Johnson had a net margin of 1.70% and a return on equity of 27.80%. The firm had revenue of $20.20 billion during the quarter, compared to the consensus estimate of $20.08 billion. During the same quarter in the prior year, the firm earned $1.58 EPS. Johnson & Johnson’s revenue for the quarter was up 11.5% on a year-over-year basis. research analysts anticipate that Johnson & Johnson will post 8.08 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 13th. Shareholders of record on Tuesday, February 27th will be given a dividend of $0.84 per share. The ex-dividend date of this dividend is Monday, February 26th. This represents a $3.36 dividend on an annualized basis and a yield of 2.59%. Johnson & Johnson’s payout ratio is currently 861.54%.

ILLEGAL ACTIVITY NOTICE: This piece was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece on another domain, it was illegally copied and reposted in violation of international trademark and copyright laws. The original version of this piece can be viewed at https://www.dispatchtribunal.com/2018/02/14/state-board-of-administration-of-florida-retirement-system-has-508-80-million-holdings-in-johnson-johnson-jnj.html.

Johnson & Johnson Company Profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply